Charles River Laboratories (CRL)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	22,203	423,782	441,514	444,453	474,624	474,950	484,034	496,335	486,226	436,394	443,347	422,474	390,982	396,595	396,078	375,065	364,304	301,461	271,362	247,655
Revenue (ttm)	US$ in thousands	4,086,133	4,070,653	4,059,413	4,065,363	4,086,910	4,314,900	4,293,342	4,227,890	4,106,274	3,792,022	3,683,743	3,605,712	3,459,843	3,333,185	3,172,755	2,930,880	2,859,828	2,759,976	2,697,739	2,671,095
Net profit margin		0.54%	10.41%	10.88%	10.93%	11.61%	11.01%	11.27%	11.74%	11.84%	11.51%	12.04%	11.72%	11.30%	11.90%	12.48%	12.80%	12.74%	10.92%	10.06%	9.27%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $22,203K ÷ $4,086,133K
= 0.54%

The net profit margin of Charles River Laboratories has displayed fluctuations over the reported periods. Starting at 9.27% on March 31, 2020, it gradually increased to 12.80% on March 31, 2021. It then fluctuated around this level before experiencing a slight decline to 10.41% on September 30, 2024. However, there was a substantial drop to 0.54% on December 31, 2024, which could indicate potential financial challenges or one-time events impacting profitability. Overall, sustained monitoring and analysis of the company's financial performance will be necessary to understand the factors influencing these variations in net profit margin.